Swallowing and Nutritional Treatment on OD Patients (OD)

October 16, 2019 updated by: Nallely Bueno Hernández, Hospital General de Mexico

Effect of Swallowing Rehabilitation Complemented With Nutritional Treatment on the Nutritional Status of Oropharyngeal Dysphagia Patients

Dysphagia is a difficulty during the swallowing process (transportation food from the mouth to the stomach. Oropharyngeal Dysphagia (OD) is diagnosed by videofluoroscopy and faringolaringoscopy. OD threatens the efficacy and safety of swallowing, contributing to an increased risk of aspiration and pneumonia. There are different interventions aimed to change and improve the physiology of swallowing; however, OD can be an important predictor of the progression of malnutrition in different types of patients. Malnutrition is defined as an acute or chronic disease whereby an energy imbalance, lack of energy, protein or other nutrients causes measurable and adverse effects on body composition, functional and clinical outcomes. In addition, it leads to a decrease in the quality of life.

Objective: To establish a strategy of nutritional treatment and swallowing rehabilitation in patients with dysphagia.

Hypothesis: An adequate nutritional intervention in content and consistency, combined with swallowing rehabilitation in patients with dysphagia, will improve the nutritional status and clinical evolution of patients with dysphagia.

Study Overview

Status

Unknown

Detailed Description

Introduction: Dysphagia is a difficulty during the swallowing process (transportation food from the mouth to the stomach. Oropharyngeal Dysphagia (OD) is diagnosed by videoflouroscopy and faringolaringoscopy and it is frequently associated with neurodegenerative problems. OD threatens the efficacy and safety of swallowing, contributing to an increased risk of aspiration and pneumonia.

Problem statement: There are different interventions aimed to change and improve the physiology of swallowing; however, OD can be an important predictor of the progression of malnutrition in different types of patients. Malnutrition is defined as an acute or chronic disease whereby an energy imbalance, lack of energy, protein or other nutrients causes measurable and adverse effects on body composition, functional and clinical outcomes. In addition, it leads to a decrease in the quality of life.

Justification: It is essential to provide adequate nutritional interventions according to the specifications of the dysphagia in order to improve the nutritional status of these patients, as well to provide adequate early nutritional treatment when changing from tube to oral feeding, focusing on dietary factors that can significantly improve nutrition of the patient. However, there are no studies that evaluate the specific requirements for the nutritional treatment of these patients. By implementing a diet based on improving the safety and efficacy of swallowing in patients with OD, specific nutritional recommendations that impact on the rate of malnutrition and mortality of the different pathologies that present this condition could be established.

Objective: To establish a strategy of nutritional treatment and swallowing rehabilitation in patients with dysphagia.

Hypothesis: An adequate nutritional intervention in content and consistency, combined with swallowing rehabilitation in patients with dysphagia, will improve the nutritional status and clinical evolution of patients with dysphagia.

Methodology: This is a prospective randomized controlled clinical trial, in which OD patients will be recruited to participate. The participants will be receiving swallowing rehabilitation by a specialist phoniatrician. They will be randomise assigned to a special nutritional treatment during 12 weeks. Swallowing rehabilitation, laboratory analyses, anthropometric measurements and consume and quality of life questionaries will be carried out.

Study Type

Interventional

Enrollment (Anticipated)

68

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Cuauhtemoc
      • Mexico City, Cuauhtemoc, Mexico, 06720
        • Nallely Bueno Hernández

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 75 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Both sexes
  • 18 to 75 years old
  • Diagnosis of dysphagia
  • Full phonological assessment
  • Any federative entity in the country

Exclusion Criteria:

  • Patients with any nephropathy
  • HIV diagnosis
  • Thyroid dysfunction dignosis
  • Gastrostomy feeded patients
  • Patients on chemotherapy
  • Psychogenic Dysphagia

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Personalized diet
Personalized diet during the swallowing rehabilitation
Modified texture and volumen diet according to the OD specifications
Active Comparator: Control
Nutritional recommendations during the swallowing rehabilitation
Nutritional Recommendations according to the OD specifications
Other Names:
  • Nutritional Recommendations

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Nutritional intervention and swallowing rehabilitation on nutritional status of OD patients
Time Frame: Participants will be evaluated at weeks 1, 6 and 12
Changes from baseline anthropometric, biochemical, and body composition values, at 12 weeks of nutritional intervention in OD patients
Participants will be evaluated at weeks 1, 6 and 12

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Swallowing capacity
Time Frame: Participants will be evaluated at weeks 1, 6 and 12
Changes from baseline of the presence or absence of food remains in the larynx and aspiration during the Fibroendoscopic Evaluation of Swallowing at 12 weeks of nutritional intervention in OD patients
Participants will be evaluated at weeks 1, 6 and 12
Body composition analysis
Time Frame: Participants will be evaluated at weeks 1, 6 and 12
Changes from baseline of the percentage of body fat, muscle and water at 12 weeks of nutritional intervention, using RJL System IV
Participants will be evaluated at weeks 1, 6 and 12
Quality of life
Time Frame: Participants will be evaluated at weeks 1, 6 and 12
Changes from baseline of WHOQOL- BREF questionary score (the higher score, the higher quality of life represents) at 12 weeks of nutritional intervention in OD patients
Participants will be evaluated at weeks 1, 6 and 12
Anthropometric measurements
Time Frame: Participants will be evaluated at weeks 1, 6 and 12
Changes from baseline of arm, waist and hips circumferences in centimeters at 12 weeks of nutritional intervention in OD patients
Participants will be evaluated at weeks 1, 6 and 12
Nutritional Risk
Time Frame: Participants will be evaluated at weeks 1, 6 and 12
Changes from baseline of malnutrition risk during the Malnutrition Universal Screening Tool score (0 = low risk; 1= medium risk 2= high risk) at 12 weeks of nutritional intervention in OD patients.
Participants will be evaluated at weeks 1, 6 and 12
Gastrointestinal symptoms
Time Frame: Participants will be evaluated at weeks 1, 6 and 12
Changes from baseline in the presence or absence of gastrointestinal symptoms according to the ROME III criteria at 12 weeks of nutritional intervention in OD patients
Participants will be evaluated at weeks 1, 6 and 12
Dietary intake
Time Frame: Participants will be evaluated at weeks 1, 6 and 12
Changes from baseline of grams of macronutrients (carbohydrates, lipids and protein) consumed, according to the 24 hours record at 12 weeks of nutritional intervention in OD patients
Participants will be evaluated at weeks 1, 6 and 12
Blood quemistry
Time Frame: Participants will be evaluated at weeks 1 and 12
Changes from baseline glucose, creatinine, high density lipoproteins, low density lipoproteins, cholesterol levels (mg/dL) at 12 weeks of nutritional intervention in OD patients
Participants will be evaluated at weeks 1 and 12
Blood chemistry
Time Frame: Participants will be evaluated at weeks 1 and 12
Changes from baseline calcium, albumin, hemoglobin levels (g/dL) and iron (ug/dL) levels at 12 weeks of nutritional intervention in OD patients
Participants will be evaluated at weeks 1 and 12
Electrolytes blood levels
Time Frame: Participants will be evaluated at weeks 1 and 12
Changes from baseline sodium and potasium levels (meq/L) at 12 weeks of nutritional intervention in OD patients
Participants will be evaluated at weeks 1 and 12

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

December 3, 2019

Primary Completion (Anticipated)

February 1, 2020

Study Completion (Anticipated)

December 30, 2020

Study Registration Dates

First Submitted

October 8, 2019

First Submitted That Met QC Criteria

October 16, 2019

First Posted (Actual)

October 18, 2019

Study Record Updates

Last Update Posted (Actual)

October 18, 2019

Last Update Submitted That Met QC Criteria

October 16, 2019

Last Verified

October 1, 2019

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Oropharyngeal Dysphagia

Clinical Trials on Personalized diet

Subscribe